Literature DB >> 4108933

Inactivation of polykaryocytogenic and hemolytic activities of Sendai virus by phospholipase B (lysolecithinase).

G Barbanti-Brodano, L Possati, M La Placa.   

Abstract

Evidence is presented that lysolecithin is involved in the fusing and hemolytic activities of Sendai virus. Treatment of the virus with phospholipase B (lysolecithinase) specifically inactivates the hemolytic and fusing abilities, without affecting the infectivity and the capability of the virus to hemagglutinate and adsorb to cells. The possible identity of lysolecithin with the "cell fusion factor" of paramyxoviruses and the mechanism of cell fusion are discussed.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4108933      PMCID： PMC376262     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  8 in total

1.  EFFECT OF TRYPSIN TREATMENT ON THE HAEMOLYTIC, HAEMAGGLUTINATING, NEURAMINIDASE AND ADENOSINE DIPHOSPHATASE ACTIVITIES OF SENDAI VIRUS.

Authors:  A R NEURATH
Journal:  Acta Virol       Date:  1963-11       Impact factor: 1.162

2.  POLYKARYOCYTOSIS INDUCED BY NEWCASTLE DISEASE VIRUS IN MONOLAYERS OF ANIMAL CELLS.

Authors:  A KOHN
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

3.  [The lipid nature of substances responsible for the hemolytic activity of Myxo-virus paraninfluenzae I (Sendai virus)].

Authors:  G REBEL; R FONTANGES; L COLOBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-02

4.  Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis.

Authors:  G Barbanti-Brodano; S Oyanagi; M Katz; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

5.  The lipids of paramyxoviruses: a comparative study of Sendai and Newcastle disease viruses.

Authors:  H A Blough; D E Lawson
Journal:  Virology       Date:  1968-10       Impact factor: 3.616

6.  Studies on Sendai virus cell fusion factor.

Authors:  M A Guggenheim; S Tyrrell; A S Rabson
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

7.  Metabolism of lecithin and virus-induced cell fusion.

Authors:  P Elsbach; K V Holmes; P W Choppin
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

8.  Lysolecithin and cell fusion.

Authors:  A R Poole; J I Howell; J A Lucy
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962
  8 in total
  7 in total

1.  Malignant transformation of hamster kidney cells by BK virus.

Authors:  M Portolani; G Barbanti-Brodano; M L Placa
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

2.  Increased immunogenicity of TSTA on heterokaryocytes of syngeneic tumoral and allogeneic normal cells.

Authors:  G Barbanti-Brodano; A T Di Marco; L Possati; C Franceschi; G Prodi
Journal:  Experientia       Date:  1974-08-15

3.  Structure and function relationships of the envelope of measles virus.

Authors:  W W Hall; S J Martin
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

4.  Temperature-dependent inhibition of fusion from without.

Authors:  W R Gallaher; M A Bratt
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

Review 5.  Early events in cell-animal virus interactions.

Authors:  S Dales
Journal:  Bacteriol Rev       Date:  1973-06

6.  The biochemistry of virus-induced cell fusion. Changes in membrane integrity.

Authors:  C A Pasternak; K J Micklem
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

7.  Inhibition of cellular differentiation by phospholipase C. I. Effects of the enzyme on myogenesis and chondrogenesis in vitro.

Authors:  M Nameroff; J A Trotter; J M Keller; E Munar
Journal:  J Cell Biol       Date:  1973-07       Impact factor: 10.539
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.